Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy
Open Access
- 1 August 2004
- journal article
- review article
- Published by Wiley in European Journal of Heart Failure
- Vol. 6 (5) , 673-676
- https://doi.org/10.1016/j.ejheart.2004.07.007
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failureEuropean Journal of Heart Failure, 2004
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Tolerability of carvedilol in heart failure: clinical trials experienceThe American Journal of Cardiology, 2004
- Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialThe Lancet, 2003
- Cardiac Resynchronization and Death From Progressive Heart FailureJAMA, 2003
- FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristicsFundamental & Clinical Pharmacology, 2002
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001